Fulgent Genetics to Announce Second Quarter 2018 Financial Results on Monday August 6, 2018
16 juil. 2018 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2018...
Fulgent Genetics Reports First Quarter 2018 Financial Results
07 mai 2018 16h05 HE
|
Fulgent Genetics, Inc.
First Quarter 2018 Results: Revenue of $4.7 million, up 9% sequentiallyBillable tests delivered grew 10% sequentially to 4,621GAAP loss of $1.9 million, or $0.11 per shareNon-GAAP loss of $1.2...
Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
23 avr. 2018 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2018...
Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
28 févr. 2018 16h05 HE
|
Fulgent Genetics, Inc.
Fourth Quarter of 2017 Results: Revenue of $4.3 millionGAAP loss of $1.8 million, or $0.10 per shareNon-GAAP loss of $1.0 million, or $0.06 per shareAdjusted EBITDA loss of $952,000 Full Year 2017...
Representatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare Conference
23 févr. 2018 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
13 févr. 2018 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full...
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 29th Annual Healthcare Conference
14 nov. 2017 08h30 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics Reports Third Quarter 2017 Financial Results
06 nov. 2017 16h05 HE
|
Fulgent Genetics, Inc.
Revenue of $4.5 MillionGAAP Loss of $1.1 million, or $0.06 per ShareNon-GAAP loss of $442,000, or $0.02 per ShareAdjusted EBITDA loss of $458,000 TEMPLE CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE)...
Representatives of Fulgent Genetics to Participate in the Credit Suisse 26th Annual Healthcare Conference
24 oct. 2017 08h30 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics to Announce Third Quarter 2017 Financial Results on November 6, 2017
23 oct. 2017 08h30 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2017...